Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
Favoni V, Giani L, Al-Hassany L, Asioli GM, Butera C, de Boer I, Guglielmetti M, Koniari C, Mavridis T, Vaikjärv M, Verhagen I, Verzina A, Zick B, Martelletti P, Sacco S; European Headache Federation School of Advanced Studies (EHF-SAS). Favoni V, et al. Among authors: guglielmetti m. J Headache Pain. 2019 Mar 12;20(1):27. doi: 10.1186/s10194-019-0979-y. J Headache Pain. 2019. PMID: 30866804 Free PMC article. Review.
Migraine and cluster headache show impaired neurosteroids patterns.
Koverech A, Cicione C, Lionetto L, Maestri M, Passariello F, Sabbatini E, Capi M, De Marco CM, Guglielmetti M, Negro A, Di Menna L, Simmaco M, Nicoletti F, Martelletti P. Koverech A, et al. Among authors: guglielmetti m. J Headache Pain. 2019 May 27;20(1):61. doi: 10.1186/s10194-019-1005-0. J Headache Pain. 2019. PMID: 31132992 Free PMC article.
The future of pharmacogenetics in the treatment of migraine.
Borro M, Guglielmetti M, Simmaco M, Martelletti P, Gentile G. Borro M, et al. Among authors: guglielmetti m. Pharmacogenomics. 2019 Nov;20(16):1159-1173. doi: 10.2217/pgs-2019-0069. Epub 2019 Oct 22. Pharmacogenomics. 2019. PMID: 31637960
Medication overuse and drug addiction: a narrative review from addiction perspective.
Takahashi TT, Ornello R, Quatrosi G, Torrente A, Albanese M, Vigneri S, Guglielmetti M, Maria De Marco C, Dutordoir C, Colangeli E, Fuccaro M, Di Lenola D, Spuntarelli V, Pilati L, Di Marco S, Van Dycke A, Abdullahi RA, Maassen van den Brink A, Martelletti P; European Headache Federation School of Advanced Studies (EHF-SAS). Takahashi TT, et al. Among authors: guglielmetti m. J Headache Pain. 2021 Apr 28;22(1):32. doi: 10.1186/s10194-021-01224-8. J Headache Pain. 2021. PMID: 33910499 Free PMC article. Review.
Fremanezumab for the prevention of chronic and episodic migraine.
Lionetto L, Cipolla F, Guglielmetti M, Martelletti P. Lionetto L, et al. Among authors: guglielmetti m. Drugs Today (Barc). 2019 Apr;55(4):265-276. doi: 10.1358/dot.2019.55.4.2970909. Drugs Today (Barc). 2019. PMID: 31050694 Review.
Emerging drugs for migraine treatment: an update.
Lambru G, Andreou AP, Guglielmetti M, Martelletti P. Lambru G, et al. Among authors: guglielmetti m. Expert Opin Emerg Drugs. 2018 Dec;23(4):301-318. doi: 10.1080/14728214.2018.1552939. Epub 2018 Nov 30. Expert Opin Emerg Drugs. 2018. PMID: 30484333 Review.
Fremanezumab for the preventive treatment of migraine in adults.
Lionetto L, Curto M, Cisale GY, Capi M, Cipolla F, Guglielmetti M, Martelletti P. Lionetto L, et al. Among authors: guglielmetti m. Expert Rev Clin Pharmacol. 2019 Aug;12(8):741-748. doi: 10.1080/17512433.2019.1635452. Epub 2019 Jun 26. Expert Rev Clin Pharmacol. 2019. PMID: 31220963 Review.
Approaching the appropriate pharmacotherapy of menstrual migraine.
Martelletti P, Guglielmetti M. Martelletti P, et al. Among authors: guglielmetti m. Expert Rev Neurother. 2020 Jan;20(1):1-2. doi: 10.1080/14737175.2020.1693265. Epub 2019 Nov 18. Expert Rev Neurother. 2020. PMID: 31738604 No abstract available.
96 results